Skip to content

Clinical trials

Mesothelioma, Malignant trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20111
20131
20152
20161
20192
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Morphotek2
NovoCure Ltd.2
AGC Biologics S.p.A.1
Alfacell1
AstraZeneca1
European Organisation for Research and Treatment of Cancer - EORTC1
Ferring Ventures Limited1
HSK Wiesbaden1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant14
Appendiceal Neoplasms1
Ascites1
Colorectal Neoplasms1
Gallbladder Neoplasms1
Mesothelioma1
Ovarian Neoplasms1
Pancreatic Neoplasms1
Peritoneal Neoplasms1
Pleural Effusion1

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.